Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 5Brain Neoplasms 4Glioma 3Central Nervous System Neoplasms 2Astrocytoma 2Oligodendroglioma 1Newly Diagnosed High Grade Glioma 1Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Follicular 1Gliosarcoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Filgrastim 9Temozolomide 8Carboplatin 5Peripheral Blood Stem Cell Transplantation 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3sargramostim 2Vorinostat 2Vincristine 2Topotecan 2Thiotepa 2Melphalan 2Irinotecan 2Erlotinib Hydrochloride 2Cyclophosphamide 2veliparib 1trioctyl phosphine oxide 1sodium thiosulfate 1romidepsin 1ribociclib 1pembrolizumab 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1exatecan 1etoposide phosphate 1emvododstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Familial ependymoma × Lomustine × Clear all
NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡